Sikhulile Moyo

Sikhulile Moyo is a Laboratory Director and Research Scientist at the Botswana Harvard Health Partnership (BHP) in Gaborone, formerly the Botswana Harvard AIDS Institute Partnership, and a Research Associate at the Harvard T.H. Chan School of Public Health, Boston, USA. He is also an Extraordinary Professor at Stellenbosch University, Western Cape, South Africa, and an adjunct scholar at the University of Botswana, Gaborone, Botswana and the University of Pretoria, Gauteng, South Africa.

He oversees laboratory support for clinical trials at BHP, including management of an ISO-accredited laboratory and Clinical Trials Unit (CTU) activities, biorepository management, protocol development and implementation, as well as training and capacity building.

His research interests include pathogen genomics across multiple pathogens, viral evolution, drug resistance, molecular epidemiology and phylogenetics, with applications for public health interventions. He is involved in studies characterising early HIV-1 subtype C infection, HIV cure and viral reservoirs, and approaches for estimating HIV incidence.

His laboratory contributes to clinical trials, observational studies and pathogen genomics research on HIV, SARS-CoV-2, hepatitis viruses, human papillomavirus, tuberculosis, sapovirus, norovirus and sexually transmitted infections. His work has also contributed to prevention of mother-to-child transmission studies, HIV incidence surveillance, HIV drug resistance monitoring and the study of emerging viral variants.